Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rosito

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Italian Journal of Orthopaedics and Traumatology|December 1, 1991
Non-metastatic Ewing's sarcoma: results in 98 patients treated with neoadjuvant chemotherapyG Bacci, S Ferrari, M Avella, et al.
Minerva Pediatrica|November 1, 1995
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)]G Bacci, S Ferrari, P Rosito, et al.
Minerva Chirurgica|April 1, 1997
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy]G Bacci, S Ferrari, P Rosito, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1988
Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary resultsG Bacci, M Avella, A Brach Del Prevert, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1993
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studiesG Bacci, P Picci, P Ruggieri, et al.
Cancer|March 20, 1998
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studiesG Bacci, P Picci, S Ferrari, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|March 1, 1985
[Neuroblastoma metastatic to the skull. Radiologic aspects and therapeutic problems]A F Mancini, P Rosito, M C Capucci, et al.
Acta Oncologica (Stockholm, Sweden)|March 2, 1999
Predictive factors of histological response to primary chemotherapy in Ewing's sarcomaG Bacci, P Picci, M Mercuri, et al.
Haematologica|November 1, 1986
Case report of a t(4;11)--associated acute leukemiaA Zaccaria, P Rosito, A F Mancini, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2003
Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992G Bacci, C Forni, A Longhi, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Italian Journal of Orthopaedics and Traumatology|December 1, 1991
Non-metastatic Ewing's sarcoma: results in 98 patients treated with neoadjuvant chemotherapyG Bacci, S Ferrari, M Avella, et al.
Minerva Pediatrica|November 1, 1995
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)]G Bacci, S Ferrari, P Rosito, et al.
Minerva Chirurgica|April 1, 1997
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy]G Bacci, S Ferrari, P Rosito, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1988
Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary resultsG Bacci, M Avella, A Brach Del Prevert, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1993
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studiesG Bacci, P Picci, P Ruggieri, et al.
Cancer|March 20, 1998
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studiesG Bacci, P Picci, S Ferrari, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|March 1, 1985
[Neuroblastoma metastatic to the skull. Radiologic aspects and therapeutic problems]A F Mancini, P Rosito, M C Capucci, et al.
Acta Oncologica (Stockholm, Sweden)|March 2, 1999
Predictive factors of histological response to primary chemotherapy in Ewing's sarcomaG Bacci, P Picci, M Mercuri, et al.
Haematologica|November 1, 1986
Case report of a t(4;11)--associated acute leukemiaA Zaccaria, P Rosito, A F Mancini, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2003
Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992G Bacci, C Forni, A Longhi, et al.
Pageof 8